ALK
Drug: Crizotinib
Cancer code: DLBC
Cancer type: B_cell_lymphoma
Drug treatment table
| Cell line ID |
Cell line name |
Mutation in substructure |
IC50(uM) |
| SIDM00859 | Farage | A_loop (1289) | 23.7331 |
| SIDM00859 | Farage | A_loop (1289) | 13.3236 |
| SIDM00416 | VAL | None | 17.8409 |
| SIDM00413 | WSU-DLCL2 | None | 18.4427 |
| SIDM00886 | DB | None | 22.4507 |
| SIDM00981 | DOHH-2 | None | 1.7277 |
| SIDM01008 | KARPAS-422 | None | 5.2921 |
| SIDM01205 | TUR | None | 2.688 |
| SIDM00896 | BC-1 | None | 1.1606 |
| SIDM00384 | SCC-3 | None | 0.2723 |
| SIDM00502 | A4-Fuk | None | 0.8263 |
| SIDM00495 | A3-KAW | None | 1.5818 |
| SIDM01058 | GRANTA-519 | None | 53.4661 |
| SIDM00688 | JSC-1 | None | 11.7043 |
| SIDM01011 | KARPAS-1106P | None | 21.5262 |
| SIDM00448 | RC-K8 | None | 34.8571 |
| SIDM00374 | SLVL | None | 5.1746 |
| SIDM00389 | SU-DHL-10 | None | 4.661 |
| SIDM00406 | SU-DHL-5 | None | 5.7417 |
| SIDM00407 | SU-DHL-6 | None | 2.4093 |
| SIDM00423 | SU-DHL-8 | None | 2.6639 |
| SIDM00323 | TK | None | 8.4344 |
| SIDM00416 | VAL | None | 11.0429 |
| SIDM00886 | DB | None | 43.612 |
| SIDM00981 | DOHH-2 | None | 4.7232 |
| SIDM00661 | HT | None | 19.0303 |
| SIDM01008 | KARPAS-422 | None | 17.7127 |
| SIDM00637 | MC116 | None | 3.581 |
| SIDM01205 | TUR | None | 9.4519 |
| SIDM01089 | RL | None | 24.4276 |
| SIDM00895 | BC-3 | None | 11.0773 |
| SIDM00896 | BC-1 | None | 7.5953 |
| SIDM00384 | SCC-3 | None | 0.883 |
| SIDM00502 | A4-Fuk | None | 2.9963 |
| SIDM00495 | A3-KAW | None | 4.7168 |
| SIDM00283 | CTB-1 | None | 16.9407 |
| SIDM01058 | GRANTA-519 | None | 16.942 |
| SIDM00689 | JM1 | None | 5.4257 |
| SIDM00688 | JSC-1 | None | 7.3555 |
| SIDM00443 | NU-DUL-1 | None | 7.2422 |
| SIDM00460 | OCI-LY-19 | None | 5.271 |
| SIDM00374 | SLVL | None | 15.1359 |
| SIDM00404 | SU-DHL-16 | None | 4.2902 |
| SIDM00405 | SU-DHL-4 | None | 5.6587 |
| SIDM00407 | SU-DHL-6 | None | 4.7204 |
| SIDM00423 | SU-DHL-8 | None | 3.7393 |